{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:17:26Z","timestamp":1792297046608,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T00:00:00Z","timestamp":1350950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T00:00:00Z","timestamp":1350950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms2149","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T12:47:49Z","timestamp":1350996469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease"],"prefix":"10.1038","volume":"3","author":[{"given":"Soosung","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara F.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon","family":"Dusel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hao","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. James","family":"Surmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,23]]},"reference":[{"key":"BFncomms2149_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368\u2013376 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFncomms2149_CR2","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley, J. M. & Lees, A. J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114, 2283\u20132301 (1991).","journal-title":"Brain"},{"key":"BFncomms2149_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF01249445","volume":"38","author":"P Riederer","year":"1976","unstructured":"Riederer, P. & Wuketich, S. Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis. J. Neural. Transm. 38, 277\u2013301 (1976).","journal-title":"J. Neural. Transm."},{"key":"BFncomms2149_CR4","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/ajmg.b.31122","volume":"153B","author":"F Casamassima","year":"2010","unstructured":"Casamassima, F. et al. L-type calcium channels and psychiatric disorders: a brief review. Am. J. Med. Genet. Part B 153B, 1373\u20131390 (2010).","journal-title":"Am. J. Med. Genet. Part B"},{"key":"BFncomms2149_CR5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/nature05865","volume":"447","author":"CS Chan","year":"2007","unstructured":"Chan, C. S. et al. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447, 1081\u20131086 (2007).","journal-title":"Nature"},{"key":"BFncomms2149_CR6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nature09536","volume":"468","author":"JN Guzman","year":"2010","unstructured":"Guzman, J. N. et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468, 696\u2013700 (2010).","journal-title":"Nature"},{"key":"BFncomms2149_CR7","doi-asserted-by":"publisher","first-page":"11011","DOI":"10.1523\/JNEUROSCI.2519-09.2009","volume":"29","author":"JN Guzman","year":"2009","unstructured":"Guzman, J. N., S\u00e1nchez-Padilla, J., Chan, C. S. & Surmeier, D. J. Robust pacemaking in substantia nigra dopaminergic neurons. J. Neurosci. 29, 11011\u201311009 (2009).","journal-title":"J. Neurosci."},{"key":"BFncomms2149_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1023\/A:1023632419813","volume":"23","author":"DJ Triggle","year":"2003","unstructured":"Triggle, D. J. 1,4-Dihydropyridines as calcium channel ligands and privileged structures. Cell Mol. Neurobiol. 23, 293\u2013303 (2003).","journal-title":"Cell Mol. Neurobiol."},{"key":"BFncomms2149_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/0895-7061(96)00013-1","volume":"9","author":"M Epstein","year":"1996","unstructured":"Epstein, M. Calcium antagonists: still appropriate as first line antihypertensive agents. Am. J. Hypertens. 9, 110\u2013121 (1996).","journal-title":"Am. J. Hypertens."},{"key":"BFncomms2149_CR10","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1212\/01.wnl.0000303818.38960.44","volume":"70","author":"C Becker","year":"2008","unstructured":"Becker, C., Jick, S. S. & Meier, C. R. Use of antihypertensives and the risk of Parkinson disease. Neurology 70, 1438\u20131444 (2008).","journal-title":"Neurology"},{"key":"BFncomms2149_CR11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ana.21937","volume":"67","author":"B Ritz","year":"2010","unstructured":"Ritz, B. et al. L-type calcium channel blockers and Parkinson disease in Denmark. Ann. Neurol. 67, 600\u2013606 (2010).","journal-title":"Ann. Neurol."},{"key":"BFncomms2149_CR12","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1523\/JNEUROSCI.21-16-05944.2001","volume":"21","author":"W Xu","year":"2001","unstructured":"Xu, W. & Lipscombe, D. Neuronal CaV1.3\u03b11 L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines. J. Neurosci. 21, 5944\u20135951 (2001).","journal-title":"J. Neurosci."},{"key":"BFncomms2149_CR13","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.57.4.5","volume":"57","author":"WA Catterall","year":"2005","unstructured":"Catterall, W. A., Perez-Reyes, E., Snutch, T. P. & Striessnig, J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol. Rev. 57, 411\u2013425 (2005).","journal-title":"Pharmacol. Rev."},{"key":"BFncomms2149_CR14","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1152\/jn.00486.2004","volume":"92","author":"D Lipscombe","year":"2004","unstructured":"Lipscombe, D., Helton, T. D. & Xu, W. L-type calcium channels: the low down. J. Neurophysiol. 92, 2633\u20132641 (2004).","journal-title":"J. Neurophysiol."},{"key":"BFncomms2149_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1124\/mol.108.049981","volume":"75","author":"MJ Sinnegger-Brauns","year":"2009","unstructured":"Sinnegger-Brauns, M. J. et al. Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol. Pharmacol. 75, 407\u2013414 (2009).","journal-title":"Mol. Pharmacol."},{"key":"BFncomms2149_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1749-6632.1991.tb36487.x","volume":"635","author":"DJ Triggle","year":"1991","unstructured":"Triggle, D. J. et al. Synthetic organic ligands active at voltage-gated calcium channels. Ann. N Y Acad. Sci. 635, 123\u2013138 (1991).","journal-title":"Ann. N Y Acad. Sci."},{"key":"BFncomms2149_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2174\/138161206775474503","volume":"12","author":"DJ Triggle","year":"2006","unstructured":"Triggle, D. J. L-type calcium channels. Curr. Pharmaceut. Des. 12, 443\u2013457 (2006).","journal-title":"Curr. Pharmaceut. Des."},{"key":"BFncomms2149_CR18","first-page":"125","volume":"114","author":"E Sullivan","year":"1999","unstructured":"Sullivan, E., Tucker, E. M. & Dale, L. Measurement of [Ca2+] using the fluorometric imaging plate reader (FLIPR). Meth. Mol. Biol. 114, 125\u201333 (1999).","journal-title":"Meth. Mol. Biol."},{"key":"BFncomms2149_CR19","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.1016\/S0021-9258(18)83165-9","volume":"264","author":"A Minta","year":"1989","unstructured":"Minta, A., Kao, J. P. Y. & Tsien, R. Y. Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J. Biol. Chem. 264, 8171\u20138178 (1989).","journal-title":"J. Biol. Chem."},{"key":"BFncomms2149_CR20","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1016\/j.bmc.2010.03.038","volume":"18","author":"C-C Chang","year":"2010","unstructured":"Chang, C.- C. et al. Antagonism of 4-substituted 1,4-dihydropyridine-3,5-dicarboxylates toward voltage-dependent L-type Ca2+ channels CaV1.3 and CaV1.2. Bioorg. Med. Chem. 18, 3147\u20133158 (2010).","journal-title":"Bioorg. Med. Chem."},{"key":"BFncomms2149_CR21","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1021\/jm101549k","volume":"54","author":"G Xia","year":"2010","unstructured":"Xia, G. et al. Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosis. J. Med. Chem. 54, 2409\u20132421 (2010).","journal-title":"J. Med. Chem."},{"key":"BFncomms2149_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/andp.18280880206","volume":"88","author":"F W\u00f6hler","year":"1828","unstructured":"W\u00f6hler, F. On the artificial formation of urea. Ann. Phys. Chem. 88, 253\u2013256 (1828).","journal-title":"Ann. Phys. Chem."},{"key":"BFncomms2149_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/cber.19210540519","volume":"54","author":"H Biltz","year":"1921","unstructured":"Biltz, H. & Wittek, H. Darstellug von Barbitursaure und N-Alkyl-barbitursauren. Chem. Ber. 54, 1035\u20131058 (1921).","journal-title":"Chem. Ber."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms2149","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms2149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms2149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T17:01:27Z","timestamp":1714496487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms2149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,23]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1]]}},"alternative-id":["BFncomms2149"],"URL":"https:\/\/doi.org\/10.1038\/ncomms2149","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,23]]},"assertion":[{"value":"9 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"1146"}}